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2EXPLANATORY MEMORANDUM
1. Council Regulation (EEC) No 302/93, setting up the European Monitoring
Centre for Drugs and Drug Addiction, permits, through its Article 13, the
participation of third countries in the Centre. On 5 April 1995, Norway
addressed a request to participate to the President of the Management Board
of the Centre, and after examination, the Board passed it to the
Commission recommending strongly that the request should meet with a
positive response.
2. The recommendation of the Management Board of the Centre stressed that
Norway’s participation would be advantageous to its work and that Norway
be granted the appropriate status in relation to its institutional participation.
3. On 18 July 1997, the Council adopted directives instructing the
Commission to negotiate an agreement with Norway. These contained the
following conditions.
“The agreement shall contain provisions on Norway’s participation,
including administrative participation, in the European Monitoring Centre for
Drugs and Drug Addiction, subject to adequate safeguards for the security of
the EU decision-making process. It shall also contain equitable financial
provisions for a contribution by Norway to the funding of the Centre, and
provisions concerning Norway’s participation in Reitox, rules on data
protection in relation to Norway, rules on legal personality and on the
privileges and immunities of the Centre in relation to Norway, as well as on
the jurisdiction of the Court of Justice in relation to Norway.”
4. The draft agreement was initialled on 21 July 1999. The Council is now
requested to adopt the attached proposal for a Council Decision on
the conclusion of an agreement between the European Community and
the Kingdom of Norway on the participation of the latter in the
European Monitoring Centre for Drugs and Drug Addiction.
5. The estimated cost of additional work in the Centre when set against the
contribution of Norway to the budget will result in no extra charge on the
budget of the Union.
399/0203 (CNS)
Proposal for a
COUNCIL DECISION
on the conclusion of an agreement between the European Community and the
Kingdom of Norway on the participation of Norway in the work of the
European Monitoring Centre for Drugs and Drug Addiction
THE COUNCIL OF THE EUROPEAN UNION,
Having regard to the Treaty establishing the European Community, and in particular
Article 308 in conjunction with the second sentence of the first sub-paragraph of
Article 300 (2) thereof,
Having regard to the proposal from the Commission1,
Having regard to the opinion of the European Parliament2,
Whereas:
(1) Council Regulation (EEC) No 302/93 of 8 February 1993 on the establishment
of a European Monitoring Centre for Drugs and Drug Addiction3, as amended
by Regulation (EC) No 3294/944, provides, in its Article 13, that the Centre is
to be open to the participation of non-Community countries which share the
Community’s interests and those of its Member States in the Centre's
objectives and work.
(2) The agreement between the Community and Norway on the participation of
the latter in the European Monitoring Centre for Drugs and Drug Addiction,
negotiated, on behalf of the European Community, by the Commission should
be approved,
HAS DECIDED AS FOLLOWS:
Article 1
The Agreement between the European Community and the Kingdom of Norway on
the participation of Norway in the work of the European Monitoring Centre for Drugs
and Drug Addiction is approved on behalf of the Community.
The text of the Agreement is attached to this Decision.
1 OJ C
2 OJ C
3 OJ L 36, 12.2.1993, p. 1.
4 OJ L 341, 30.12.1994, p. 7.
4Article 2
The President of the Council is authorized to designate the person who shall be
empowered to sign the Agreement in order to bind the Community and to give
the notification by means of the diplomatic note provided for in Article 12 of
the Agreement.
Done at Brussels,
For the Council
The President
5Draft
Agreement between the European Community and the Kingdom of Norway
on the participation of Norway in the work of the European Monitoring Centre
for Drugs and Drug Addiction
THE CONTRACTING PARTIES,
Aware of the need for international cooperation to combat the threat of drugs and drug
addiction in society;
Reaffirming the very close cultural, commercial and social links historically
established between the European Union and Norway, especially the
economic, political and juridical links established through the European Economic
Area Agreement;
Considering that the European Community concluded, by Decision 90/611/EEC1, the
United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic
Substances, hereinafter referred to as the “Vienna Convention”, and deposited a
declaration of competence regarding Article 27 thereof2; and considering that Norway
ratified the Vienna Convention on 14 November 1994;
Considering that the European Community has established, by Council Regulation
(EEC) No 302/933 (“the Regulation”), the European Monitoring Centre for Drugs and
Drug Addiction (“the Centre”);
Whereas the Regulation provides in its Article 13 that the Centre shall be open to the
participation of those non-Community countries which share the Community’s
interests and those of its Member States; whereas Norway has made a request
to participate;
Whereas Norway shares in the aims and objectives laid down for the Centre in
the Regulation;
Whereas Norway subscribes to the description of the tasks of the Centre and to its
work method and priority areas as described in the Regulation;
Whereas there exists in Norway an institution suitable to be linked to the
European Information Network on Drugs and Drug Addiction;
1 OJ L 326, 24. 11.1990, p. 56.
2 OJ L 326, 24.11.1990, p. 57.
3 OJ L 36, 12.2.1993, p. 1.
6HAVE DECIDED TO CONCLUDE THE FOLLOWING AGREEMENT:
Article 1
Norway shall participate fully in the work of the Centre, on the terms set out in
this Agreement.
Article 2
European Information Network on Drugs and Drug Addiction (Reitox)
1. Norway shall be linked to the European Information Network on Drugs and
Drug Addiction (Reitox).
2. Norway shall notify the Centre of the main elements of its national
information network within 28 days of the entry into force of this Agreement,
including its national monitoring centre, and name any other specialised
centres which could make a useful contribution to the Centre's work.
3. A specialised centre shall be designated in Norway as a national focal point,
by a unanimous decision of the members of the Management Board.
Article 3
Management Board
The Management Board of the Centre shall invite a representative of Norway to
participate in its meetings. The representative shall participate fully without the right
to vote. Nevertheless, the Management Board may convoke exceptionally a meeting
restricted to representatives of Member States and of the European Commission on
issues of interest particular to the Community and its Member States.
The Management Board, in session with representatives of Norway, will lay down
the detailed arrangements concerning the participation of Norway in the work of
the Centre.
Article 4
Scientific Committee
The Management Board of the Centre shall invite a representative of Norway to
participate fully in the meetings of the Scientific Committee without the right to vote.
7Article 5
Budget
Norway will make a payment to the Centre equivalent to 5.5% of the
European Union’s subsidy excluding the subsidy to the National focal points of the
Reitox network.
Article 6
Protection and confidentiality of data
1. Where on the basis of this Agreement personal data which do not
enable natural persons to be identified are forwarded by the Centre to
Norwegian authorities in accordance with national law, such data may be
used only for the stated purpose and under the conditions prescribed by the
forwarding authority.
2. Data on drugs and drug addiction provided to the Norwegian authorities by
the Centre may be published subject to compliance with Community and
Norwegian rules on the dissemination and confidentiality of information.
Personal data may not be published or made accessible to the public.
3. Designated specialised centres in Norway shall be under no obligation to
provide information classified as confidential under Norwegian legislation.
4. In relation to data supplied by the Norwegian authorities to the Centre, the
latter will be bound by the rules laid down in Article 6 of the Regulation.
Article 7
Legal status
The Centre shall have legal personality under Norwegian law and shall enjoy
in Norway the most extensive legal capacity accorded to legal persons under
Norwegian law.
Article 8
Liability
The liability of the Centre shall be governed by the rules laid down in Article 16 of
the Regulation.
8Article 9
Court of Justice
Norway recognises the jurisdiction of the Court of Justice of the
European Communities over the Centre, as laid down in Article 17 of the Regulation.
Article 10
Privileges
Norway shall grant privileges and immunities to the Centre equivalent to
those contained in the Protocol on the Privileges and Immunities of the
European Communities.
Article 11
Staff Regulations
By way of derogation from Article 12(2)(a) of the Conditions of employment of other
servants of the European Communities, Norwegian nationals enjoying their full rights
as citizens may be engaged under contract by the Executive Director of the Centre.
Article 12
Entry into force
This Agreement shall enter into force on the first day of the second month following
the date of receipt of the latter diplomatic note confirming that legal requirements of
the respective Contracting Party concerning the entry into force of the Agreement
have been fulfilled.
Article 13
Validity and termination
1. This agreement is concluded for an unlimited period.
2. Either Contracting Party may denounce this Agreement by a written
notification to the other Contracting Party. The Agreement shall cease to be
in force twelve months after the date of such notification.
9Declaration by the Commission of the European Communities
The Commission will invite the European Monitoring Centre for Drugs and Drug
Addiction, while preparing the budget, to take the fullest account of the comments
made by Norway concerning its own contribution.
